Drug profile · INN
chloroquine hydrochloride
ARALEN HYDROCHLORIDE
chloroquine hydrochloride (ARALEN HYDROCHLORIDE) is a ferriprotoporphyrin ix binding agent. Route of administration: injection. Current US regulatory status: approved.
Drug details — chloroquine hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
chloroquine hydrochloride (ARALEN HYDROCHLORIDE) is a ferriprotoporphyrin ix binding agent. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Ferriprotoporphyrin IX binding agent
Primary target: Ferriprotoporphyrin IX
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is chloroquine hydrochloride?
chloroquine hydrochloride (ARALEN HYDROCHLORIDE) is a ferriprotoporphyrin ix binding agent. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for chloroquine hydrochloride?
ARALEN HYDROCHLORIDE is a marketed brand name for chloroquine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of chloroquine hydrochloride?
chloroquine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.